Off-label drug use in palliative medicine: Delphi study for the consensus of evidence-based treatment recommendations
For many off-label use applications, it is likely that there will be no registration studies and therefore no drug approvals in the future. The consensus-based recommendations are intended to facilitate individual treatment planning for prescribers and to enable a more reflected handling of off-label use.
Authors
- Claudia Bausewein (ORCID: https://orcid.org/0000-0002-0958-3041)
- Saskia Jünger
- Constanze Rémi (ORCID: https://orcid.org/0000-0001-7655-0306)
- Stefanie Pügge (ORCID: https://orcid.org/0009-0006-4053-6012)
- Aleksandra Dukic-Ott
- Julian Baumgärtel
Institutions
- Bochum University of Applied Sciences (DE)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- Palliative Medicine
- Published
- 2025-03-15
- DOI
- https://doi.org/10.1177/02692163251323123
- Citations
- 2
- Primary Topic
- Pharmaceutical studies and practices
- Type
- article
- Field-Weighted Citation Impact
- 6.99
Funders
- Deutsche Krebshilfe